EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC-ND 4.0

Muir–Torre Syndrome Associated With a Cryptic Intronic MSH2 Variant Identified via Whole‐Genome Sequencing: A Case Report

Keisuke Noda iD, Hirokazu Kurohama iD, Katsuya Matsuda iD, Akira Kinoshita, Hiroyuki Mishima iD, Megumi Matsumoto, Riko Matsuda, Nozomi Ueki, Masao Kishikawa, Kiyonori Miura iD, Takashi Nonaka iD, Koh-Ichiro Yoshiura iD und 2 weitere

Pathology International · 2026

DOI: 10.1111/pin.70164 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Pathology International, 2026. Verfasst von Keisuke Noda und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Tumor and Diagnostic Pathology, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Ja…. Hauptthemen laut MEDLINE: MutS Homolog 2 Protein, Muir-Torre Syndrome, Carcinoma, Medullary. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Atomic Bomb Disease Institute, Nagasaki University, Program of the Network-Type Joint Usage/Research Center for Radiation Disaster Medical Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tumors exhibiting mismatch repair deficiency without detectable germline mutations via standard multigene panel testing are often classified as Lynch‐like syndrome. In the present report, we describe the case of a 47‐year‐old man presenting with synchronous axillary sebaceous carcinoma and colonic medullary carcinoma. Although initial germline multigene panel testing failed to identify pathogenic variants, a high degree of pathological suspicion for Muir–Torre syndrome remained. Immunohistochemistry revealed a concordant loss of MSH2 and MSH6 expression in both the extraocular sebaceous carcinoma and the colonic medullary carcinoma. This identical protein‐loss pattern detected across anatomically distinct tumors served as decisive pathological evidence of an underlying germline defect rather than independent biallelic somatic mutations. Consequently, whole‐genome sequencing was performed to resolve the discrepancy between the pathological findings and multigene panel testing results, successfully identifying a germline intronic MSH2 variant (NM_000251.3:c.2459‐12A>G). Subsequent RNA analysis confirmed aberrant splicing with an 11‐bp insertion. In conclusion, the present case illustrates that concordant mismatch repair protein loss across multiple tumors provides compelling morphological evidence to guide pathologists in reconsidering negative panel results and pursuing comprehensive genomic investigation to identify pathogenic intronic variants.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MutS Homolog 2 ProteinMuir-Torre SyndromeCarcinoma, MedullaryHumansMiddle AgedMaleIntronsWhole Genome SequencingGerm-Line Mutation

Stichwörter der Autor:innen

Lynch syndromeMSH2 geneMuir–Torre syndromeimmunohistochemistryintronsmismatch repair deficiencysebaceous carcinomawhole‐genome sequencing

Substanzen

MutS Homolog 2 ProteinMSH2 protein, human

Autor:innen und Institutionen

  • Department of Tumor and Diagnostic Pathology, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
  • Division of Surgical Oncology, Department of Surgery, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
  • Regional Diagnostic Pathology Support Center, Nagasaki University Hospital, Nagasaki, Japan.
  • Department of Human Genetics, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan.
  • Clinical Genomics Center, Nagasaki University Hospital, Nagasaki, Japan.
  • Nagasaki Diagnostic Pathology Clinic, Nagasaki, Japan.

ORCID-Profile: Keisuke Noda, Hirokazu Kurohama, Katsuya Matsuda, Hiroyuki Mishima, Kiyonori Miura, Takashi Nonaka, Koh-Ichiro Yoshiura, Keitaro Matsumoto, Masahiro Nakashima

Förderung

  • Atomic Bomb Disease Institute, Nagasaki University
  • Program of the Network-Type Joint Usage/Research Center for Radiation Disaster Medical Science

Zitieren

APA

Noda, K., Kurohama, H., Matsuda, K., Kinoshita, A., Mishima, H., Matsumoto, M., Matsuda, R., Ueki, N., Kishikawa, M., Miura, K., Nonaka, T., Yoshiura, K. I., Matsumoto, K., & Nakashima, M. (2026). Muir–Torre Syndrome Associated With a Cryptic Intronic MSH2 Variant Identified via Whole‐Genome Sequencing: A Case Report. Pathology International. https://doi.org/10.1111/pin.70164

Vancouver

Noda K, Kurohama H, Matsuda K, Kinoshita A, Mishima H, Matsumoto M, et al. Muir–Torre Syndrome Associated With a Cryptic Intronic MSH2 Variant Identified via Whole‐Genome Sequencing: A Case Report. Pathology International. 2026. doi:10.1111/pin.70164

BibTeX
@article{Noda2026,
  author = {Noda, Keisuke and Kurohama, Hirokazu and Matsuda, Katsuya and Kinoshita, Akira and Mishima, Hiroyuki and Matsumoto, Megumi and Matsuda, Riko and Ueki, Nozomi and Kishikawa, Masao and Miura, Kiyonori and Nonaka, Takashi and Yoshiura, Koh-Ichiro and Matsumoto, Keitaro and Nakashima, Masahiro},
  title = {Muir–Torre Syndrome Associated With a Cryptic Intronic MSH2 Variant Identified via Whole‐Genome Sequencing: A Case Report},
  journal = {Pathology International},
  year = {2026},
  doi = {10.1111/pin.70164}
}
Kostenlos starten →